Gufic BioSciences Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹251.82 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.82 per cent from ₹231.41 crore. This corresponds to a year-on-year *(YoY) growth of 22.83 per cent.
Operating Profit
Operating Profit stands at ₹47.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.15 per cent from ₹32.98 crore. This corresponds to a year-on-year *(YoY) growth of 79.03 per cent.
PBDT
PBDT stands at ₹36.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.04 per cent from ₹25.41 crore. This corresponds to a year-on-year *(YoY) growth of 99.35 per cent.
Profit Before Tax
Profit Before Tax stands at ₹28.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 63.37 per cent from ₹17.72 crore. This corresponds to a year-on-year *(YoY) growth of 175.19 per cent.
Net Profit
Net Profit stands at ₹21.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 76.33 per cent from ₹12.42 crore. This represents a 183.68 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gufic BioSciences Ltd Earnings
- YOY
- QOQ
Gufic BioSciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gufic BioSciences Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gufic BioSciences Ltd Financial Reports
Gufic BioSciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gufic BioScience | 0.86% | -2.10% | 5.34% | 27.09% | 21.27% | 9.09% |
| RPG LifeScience. | -1.04% | 1.27% | 15.99% | 29.28% | 4.96% | -3.40% |
| Unichem Labs. | 19.27% | 20.78% | 30.10% | 68.45% | 37.45% | -4.47% |
| Guj. Themis Bio. | -2.55% | -5.00% | -4.77% | 28.48% | -3.27% | 6.25% |
| SMS Pharma. | -4.56% | -4.60% | 5.44% | -4.16% | 16.13% | 70.01% |
| Novartis India | 0.10% | -0.93% | 9.86% | 45.47% | 86.04% | 35.78% |
| Advanced Enzyme | 0.57% | 0.63% | -14.15% | 7.52% | 12.33% | -3.51% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Jayesh P Choksi
ED / WTD / CEO / Promoter : Pranav J Choksi
Whole-time Director : Pankaj Gandhi
Independent Non Exe. Director : Anusanjiv Aurora
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Akshya Kumar Mahapatra
Company Sec. & Compli. Officer : Ami Naresh Shah